Oppenheimer Maintains Outperform on HCA Healthcare, Raises Price Target to $345
HCA Holdings, Inc. -0.63%
HCA Holdings, Inc. HCA | 408.17 | -0.63% |
Oppenheimer analyst Michael Wiederhorn maintains HCA Healthcare (NYSE:
HCA) with a Outperform and raises the price target from $330 to $345.